Anavex Life Sciences Corp. (AVXL) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Anavex Life Sciences Corp., updated every trading day.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
Price
$1.30
−0.76% today
Market cap
$121M
Overall quality
60/100
Kronos AI 30-day
+87.0%
8 of 8 simulated paths end higher
Anavex Life Sciences Corp. (AVXL) is a Health Care company in Biotechnology: Biological Products (No Diagnostic Substances), worth $121M. It trades at $1.30, down 0.76% today. Its overall quality score is 60 out of 100, ranked against the whole US market. Kronos AI's 30-day forecast is +87.0% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
No analyst covers this listing yet.
Kronos AI 30-day forecast
| Expected close | $2.45 (+87.0%) |
| Likely range | +74.7% … +106.6% |
| As of | 2026-10-27 |
8 of 8 simulated paths end higher.
Quality scores
| Profitability | 44 |
| Solvency | 92 |
| Growth | 43 |
| Overall | 60 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Halal Health Care stocks · Zakat calculator · Purification calculator
Similar companies in Biotechnology: Biological Products (No Diagnostic Substances)
For information only, not investment advice. Prices updated: 2026-10-29.